FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023304741> ?p ?o ?g. }

• W2023304741 endingPage "367" @default.
• W2023304741 startingPage "367" @default.
• W2023304741 abstract "Patient profiling in diabetes and role of canagliflozin Ambika Amblee1,2 1Division of Endocrinology, John H Stroger Jr Hospital of Cook County, 2Rush University Medical Center, Chicago, IL, USA Background: Physicians attempt to achieve glycemic goals in patients with type 2 diabetes mellitus (T2DM) through various means, including glucose-lowering medications. There is interindividual variability in response to medications, which can be partially explained by the presence of genetic polymorphisms that affect drug metabolism. Pharmacogenomics studies the hereditary basis of interpatient variations in drug response and aims to identify subgroups of patients whose drug management could be tailored accordingly. The aim of this review is to explore patient profiling in the management of T2DM with a focus on the sodium glucose transporter inhibitor canagliflozin. Methods: The PubMed database was searched using the terms “pharmacogenomics” and “diabetes” through May 31, 2014. Published articles and abstracts presented at national/international meetings were considered. Results and conclusion: Genome-wide association studies have opened the door for patient profiling and research into genetic variants in multifactorial T2DM. Clinically, it may be possible to tailor the type of medication used based on the presence or absence of the various genetic variants. However, the polymorphisms studied may only explain some of the variability in response to T2DM drugs and needs further validation to ensure its authenticity. There are still unidentified factors which appear to play a role in the interindividual variability seen in clinical practice. The potential exists for pharmacogenomics to promote efficacious, safe, and cost-effective individualized diabetes management. Pharmacogenomics is still in its early stages, and the idea of defining patients genetically to predict individual responses to drugs and obtain safe and effective T2DM management is promising, in spite of existing barriers. Currently, clinical profiling of patients with T2DM and using an individualized approach with most drugs, including canagliflozin, based on comorbid conditions still remains the most accepted approach for the management of T2DM. Keywords: personalized medicine, pharmacogenomics, genetic variants" @default.
• W2023304741 created "2016-06-24" @default.
• W2023304741 creator A5063962643 @default.
• W2023304741 date "2014-11-01" @default.
• W2023304741 modified "2023-09-23" @default.
• W2023304741 title "Patient profiling in diabetes and role of canagliflozin" @default.
• W2023304741 cites W1540876293 @default.
• W2023304741 cites W1542434548 @default.
• W2023304741 cites W1964841436 @default.
• W2023304741 cites W1987553321 @default.
• W2023304741 cites W1991458832 @default.
• W2023304741 cites W1996510156 @default.
• W2023304741 cites W1996837305 @default.
• W2023304741 cites W2001250643 @default.
• W2023304741 cites W2008944937 @default.
• W2023304741 cites W2010640979 @default.
• W2023304741 cites W2018409137 @default.
• W2023304741 cites W2018670288 @default.
• W2023304741 cites W2020474316 @default.
• W2023304741 cites W2020824346 @default.
• W2023304741 cites W2021809916 @default.
• W2023304741 cites W2023391486 @default.
• W2023304741 cites W2023810596 @default.
• W2023304741 cites W2024878386 @default.
• W2023304741 cites W2025514636 @default.
• W2023304741 cites W2026222639 @default.
• W2023304741 cites W2034886511 @default.
• W2023304741 cites W2046713031 @default.
• W2023304741 cites W2047944613 @default.
• W2023304741 cites W2048566593 @default.
• W2023304741 cites W2056843863 @default.
• W2023304741 cites W2060832805 @default.
• W2023304741 cites W2060922257 @default.
• W2023304741 cites W2066464954 @default.
• W2023304741 cites W2067655117 @default.
• W2023304741 cites W2068112581 @default.
• W2023304741 cites W2068171948 @default.
• W2023304741 cites W2068662257 @default.
• W2023304741 cites W2069150029 @default.
• W2023304741 cites W2072883796 @default.
• W2023304741 cites W2075627118 @default.
• W2023304741 cites W2079073137 @default.
• W2023304741 cites W2090453855 @default.
• W2023304741 cites W2098225835 @default.
• W2023304741 cites W2102956197 @default.
• W2023304741 cites W2103338840 @default.
• W2023304741 cites W2105414162 @default.
• W2023304741 cites W2109429703 @default.
• W2023304741 cites W2115088256 @default.
• W2023304741 cites W2120877247 @default.
• W2023304741 cites W2122447595 @default.
• W2023304741 cites W2130255233 @default.
• W2023304741 cites W2130570549 @default.
• W2023304741 cites W2132717133 @default.
• W2023304741 cites W2136533443 @default.
• W2023304741 cites W2136549156 @default.
• W2023304741 cites W2147804662 @default.
• W2023304741 cites W2162646492 @default.
• W2023304741 cites W2162897961 @default.
• W2023304741 cites W2165149014 @default.
• W2023304741 cites W2167504071 @default.
• W2023304741 cites W2168926920 @default.
• W2023304741 cites W2172193326 @default.
• W2023304741 cites W2323118609 @default.
• W2023304741 cites W57666350 @default.
• W2023304741 cites W99199599 @default.
• W2023304741 doi "https://doi.org/10.2147/pgpm.s52761" @default.
• W2023304741 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4270036" @default.
• W2023304741 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25540592" @default.
• W2023304741 hasPublicationYear "2014" @default.
• W2023304741 type Work @default.
• W2023304741 sameAs 2023304741 @default.
• W2023304741 citedByCount "1" @default.
• W2023304741 countsByYear W20233047412017 @default.
• W2023304741 crossrefType "journal-article" @default.
• W2023304741 hasAuthorship W2023304741A5063962643 @default.
• W2023304741 hasBestOaLocation W20233047411 @default.
• W2023304741 hasConcept C104317684 @default.
• W2023304741 hasConcept C126322002 @default.
• W2023304741 hasConcept C134018914 @default.
• W2023304741 hasConcept C135763542 @default.
• W2023304741 hasConcept C142724271 @default.
• W2023304741 hasConcept C163763905 @default.
• W2023304741 hasConcept C170734499 @default.
• W2023304741 hasConcept C17744445 @default.
• W2023304741 hasConcept C177713679 @default.
• W2023304741 hasConcept C199539241 @default.
• W2023304741 hasConcept C2777180221 @default.
• W2023304741 hasConcept C2777451236 @default.
• W2023304741 hasConcept C2779473830 @default.
• W2023304741 hasConcept C2780035454 @default.
• W2023304741 hasConcept C2780473172 @default.
• W2023304741 hasConcept C2910068830 @default.
• W2023304741 hasConcept C2994119904 @default.
• W2023304741 hasConcept C54355233 @default.
• W2023304741 hasConcept C555293320 @default.
• W2023304741 hasConcept C55775858 @default.
• W2023304741 hasConcept C60644358 @default.

• next